Kellanova
K
NYSE
IPO1959
about K
Kellanova is a biopharmaceutical company focused on developing innovative gene therapy treatments for rare and genetic disorders, particularly targeting severe unmet medical needs such as hemophilia A.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $83.06 | $83.12 | $83.06 | $28.90B | 1.34M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.86 | 22.04 | 9.08 | 13.67% | 9.46% | 2.79% |